1
|
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England.
|
Gut
|
2003
|
3.30
|
2
|
Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study.
|
Endoscopy
|
2012
|
2.58
|
3
|
Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
|
Gut
|
2004
|
1.92
|
4
|
Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001.
|
Br J Cancer
|
2006
|
1.58
|
5
|
Antibiotic use and the development of Crohn's disease.
|
Gut
|
2004
|
1.56
|
6
|
Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
|
Scand J Gastroenterol
|
2004
|
1.42
|
7
|
Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
|
Aliment Pharmacol Ther
|
2002
|
1.35
|
8
|
Fracture experience of patients with coeliac disease: a population based survey.
|
Gut
|
2003
|
1.30
|
9
|
Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study.
|
Aliment Pharmacol Ther
|
2004
|
1.22
|
10
|
Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study.
|
Gut
|
2004
|
1.17
|
11
|
Patient perceptions of the burden of coeliac disease and its treatment in the UK.
|
Aliment Pharmacol Ther
|
2009
|
1.16
|
12
|
Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study.
|
Gastroenterology
|
2005
|
1.11
|
13
|
National audit of the use of surgery and radiological embolization after failed endoscopic haemostasis for non-variceal upper gastrointestinal bleeding.
|
Br J Surg
|
2012
|
1.08
|
14
|
Mortality from acute upper gastrointestinal bleeding in the United kingdom: does it display a "weekend effect"?
|
Am J Gastroenterol
|
2011
|
1.06
|
15
|
Cigarette smoking and adult coeliac disease.
|
Scand J Gastroenterol
|
2002
|
1.01
|
16
|
Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsia.
|
Aliment Pharmacol Ther
|
2008
|
0.99
|
17
|
Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association.
|
Aliment Pharmacol Ther
|
2005
|
0.95
|
18
|
Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding.
|
Aliment Pharmacol Ther
|
2010
|
0.94
|
19
|
High prevalence of undetected ulcerative colitis: data from the Nottingham fecal occult blood screening trial.
|
Am J Gastroenterol
|
2002
|
0.92
|
20
|
The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study.
|
Aliment Pharmacol Ther
|
2012
|
0.90
|
21
|
Is an internal comparison better than using national data when estimating mortality in longitudinal studies?
|
J Epidemiol Community Health
|
2006
|
0.90
|
22
|
Genome screening of coeliac disease.
|
J Med Genet
|
2002
|
0.87
|
23
|
No seasonality in month of birth of inflammatory bowel disease cases: a prospective population based study of British under 20 year olds.
|
Gut
|
2002
|
0.84
|
24
|
Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls.
|
Aliment Pharmacol Ther
|
2004
|
0.82
|
25
|
No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study.
|
Aliment Pharmacol Ther
|
2008
|
0.81
|
26
|
Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma.
|
Br J Cancer
|
2007
|
0.80
|
27
|
Impact of the two-week referral guideline on time to diagnosis and treatment in oesophago-gastric cancer.
|
Clin Med
|
2003
|
0.79
|
28
|
Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care.
|
Aliment Pharmacol Ther
|
2008
|
0.77
|
29
|
Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease.
|
Ann Hum Genet
|
2002
|
0.76
|
30
|
The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire.
|
Gut
|
2008
|
0.75
|